J
Javier P. Gisbert
Researcher at Autonomous University of Madrid
Publications - 1076
Citations - 39753
Javier P. Gisbert is an academic researcher from Autonomous University of Madrid. The author has contributed to research in topics: Helicobacter pylori & Inflammatory bowel disease. The author has an hindex of 95, co-authored 990 publications receiving 33726 citations. Previous affiliations of Javier P. Gisbert include Services Hospital & University of Alcalá.
Papers
More filters
Journal ArticleDOI
Optimization Strategies Aimed to Increase the Efficacy of Helicobacter pylori Eradication Therapies with Quinolones
TL;DR: A quinolone (mainly levofloxacin)-containing regimen is an encouraging second-line (or even third-line) strategy, and a safe and simple alternative to bismuth quadruple therapy in patients whose previous H. pylori eradication therapy has failed.
Journal ArticleDOI
Prevalencia y características de la anemia y ferropenia en pacientes hospitalizados por enfermedades digestivas en España
Fermín Mearin,Manuel Barreiro-de Acosta,Ángel González-Galilea,Javier P. Gisbert,Mercedes Cucala,Julio Ponce +5 more
TL;DR: La prevalencia de anemia en pacientes hospitalizados por enfermedades gastroenterologicas es muy alta, en la visita de control, en mas of the cuarta parte of los pacientses persiste the anemia.
Journal ArticleDOI
Real-World Evidence of the Effectiveness and Safety of Ustekinumab for the Treatment of Crohn’s Disease: Systematic Review and Meta-Analysis of Observational Studies
TL;DR: Dose optimisation is frequently required, being effective in a high percentage of cases, and ustekinumab is an effective and safe therapy in real-world refractory CD patients.
Journal ArticleDOI
Hemorragia digestiva por úlcera péptica. ¿Se puede estimar con fiabilidad suficiente su pronóstico y evitar el ingreso de algunos pacientes?
Journal ArticleDOI
Genetic variation analysis in a follow-up study of gastric cancer precursor lesions confirms the association of MUC2 variants with the evolution of the lesions and identifies a significant association with NFKB1 and CD14.
Osmel Companioni,Catalina Bonet,Nadia García,María José Ramírez-Lázaro,Sergio Lario,J.L. Mendoza,Mª Magdalena Adrados,Elvira Poves,Laura Espinosa,José Juan Pozo-Kreilinger,Luis Ortega,Luis Bujanda,Angel Cosme,Angel Ferrandez,Guillermo Muñoz,Miriam Cuatrecasas,Ignasi Elizalde,Victoria Andreu,Ma José Paúles,Beatriz Madrigal,Jesús Barrio,María Berdasco,Xavier Calvet,José Miguel Sanz-Anquela,Javier P. Gisbert,Carlos González,Núria Sala +26 more
TL;DR: It is confirmed that genetic variability in MUC2, NFKB1 and CD14 may have a role in the evolution of the GCPLs along time and in gastric carcinogenesis.